Revision of Prior Period Financial Statements |
Revision of Prior Period Financial Statements During the fourth quarter of 2021, the Company revised the presentation of cash and cash equivalents held in a fiduciary capacity in the consolidated statements of cash flows. Historically, the Company did not present cash and cash equivalents held in a fiduciary capacity in the statements of cash flows, since these funds cannot be used for general purposes and were not considered a source of liquidity for the Company. The Company has since revised its presentation and includes cash and cash equivalents held in a fiduciary capacity as a component of total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity, in the consolidated statements of cash flows. Based on an analysis of quantitative and qualitative factors in accordance with SEC Staff Accounting Bulletins (“SAB”) No. 99 Materiality and SAB No. 108, Considering the Effects of Prior Years Misstatements When Quantifying Misstatements in Current Year Financial Statements, the Company concluded the effect of the change was not material to any previously filed interim or annual financial statements. Accordingly, the Company revised the previously reported financial information in this Annual Report on Form 10-K in the consolidated statements of cash flows and related disclosures for the years ended December 31, 2020 and 2019, and for the unaudited interim periods ended March 31, 2021, June 30, 2021 and September 30, 2021. The tables below reflect the impact to the consolidated statements of cash flows for the years ended December 31, 2020 and 2019, and to the previously filed unaudited quarterly reports on Form 10-Q for the three months ended March 31, 2021, six months ended June 30, 2021 and the nine months ended September 30, 2021: | | | | | | | | | | | | For the Years Ended December 31, | As Reported | Effect of Change | As Revised | (In millions) | 2020 | Net cash provided by operations | $ | 3,382 | | $ | — | | $ | 3,382 | | Financing cash flows: | | | | Change in fiduciary liabilities | — | | 955 | | 955 | | Other lines | (1,880) | | — | | (1,880) | | Net cash used for financing activities | $ | (1,880) | | $ | 955 | | $ | (925) | | Investing cash flows: | | | | Acquisitions, net of cash and cash held in a fiduciary capacity acquired | $ | (668) | | $ | 21 | | $ | (647) | | Other lines | (146) | | — | | (146) | | Net cash used for investing activities | $ | (814) | | $ | 21 | | $ | (793) | | Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | 246 | | 265 | | 511 | | Increase in changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | 934 | | 1,241 | | 2,175 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of year | 1,155 | | 7,344 | | 8,499 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of year | $ | 2,089 | | $ | 8,585 | | $ | 10,674 | | | 2019 | Net cash provided by operations | $ | 2,361 | | $ | — | | $ | 2,361 | | Financing cash flows: | | | | Change in fiduciary liabilities | — | | 1,025 | | 1,025 | | Other lines | 3,306 | | — | | 3,306 | | Net cash provided by financing activities | $ | 3,306 | | $ | 1,025 | | $ | 4,331 | | Investing cash flows: | | | | Acquisitions, net of cash and cash held in a fiduciary capacity acquired | $ | (5,505) | | $ | 1,276 | | $ | (4,229) | | Other | (166) | | — | | (166) | | Net cash used for investing activities | $ | (5,671) | | $ | 1,276 | | $ | (4,395) | | Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | 93 | | 42 | | 135 | | Increase in changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | 89 | | 2,343 | | 2,432 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of year | 1,066 | | 5,001 | | 6,067 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of year | $ | 1,155 | | $ | 7,344 | | $ | 8,499 | |
| | | | | | | | | | | | | (Unaudited) | As Reported | Effect of Change | As Revised | (In millions) | September 30, 2021 | Net cash provided by operations | $ | 2,074 | | $ | — | | $ | 2,074 | | Financing cash flows: | | | | Change in fiduciary liabilities | — | | 1,919 | | 1,919 | | Other lines | (2,046) | | — | | (2,046) | | Net cash used for financing activities | $ | (2,046) | | $ | 1,919 | | $ | (127) | | Investing cash flows: | | | | Acquisitions, net of cash and cash held in a fiduciary capacity acquired | $ | (401) | | $ | 17 | | $ | (384) | | Other lines | (188) | | — | | (188) | | Net cash used for investing activities | $ | (589) | | $ | 17 | | $ | (572) | | Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (130) | | (113) | | (243) | | Decrease (increase) in changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (691) | | 1,823 | | 1,132 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period | 2,089 | | 8,585 | | 10,674 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period | $ | 1,398 | | $ | 10,408 | | $ | 11,806 | | | | | | | June 30, 2021 | Net cash provided by operations | $ | 750 | | $ | — | | $ | 750 | | Financing cash flows: | | | | Change in fiduciary liabilities | — | | 1,277 | | 1,277 | | Other lines | (1,491) | | — | | (1,491) | | Net cash used for financing activities | $ | (1,491) | | $ | 1,277 | | $ | (214) | | Investing cash flows: | | | | Acquisitions, net of cash and cash held in a fiduciary capacity acquired | $ | (363) | | $ | 13 | | $ | (350) | | Other lines | (74) | | — | | (74) | | Net cash used for investing activities | $ | (437) | | $ | 13 | | $ | (424) | | Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (23) | | 61 | | 38 | | Decrease (increase) in changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (1,201) | | 1,351 | | 150 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period | 2,089 | | 8,585 | | 10,674 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period | $ | 888 | | $ | 9,936 | | $ | 10,824 | | | | | | | March 31, 2021 | Net cash provided by operations | $ | (408) | | $ | — | | $ | (408) | | Financing cash flows: | | | | Change in fiduciary liabilities | — | | 190 | | 190 | | Other lines | (451) | | — | | (451) | | Net cash used for financing activities | $ | (451) | | $ | 190 | | $ | (261) | | Investing cash flows: | | | | Acquisitions, net of cash and cash held in a fiduciary capacity acquired | $ | — | | $ | — | | $ | — | | Other lines | (67) | | — | | (67) | | Net cash used for investing activities | $ | (67) | | $ | — | | $ | (67) | | Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (43) | | 7 | | (36) | | Decrease in changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (969) | | 197 | | (772) | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period | 2,089 | | 8,585 | | 10,674 | | Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period | $ | 1,120 | | $ | 8,782 | | $ | 9,902 | |
|